ANN ARBOR, Mich., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that Tim Mayleben, president and CEO, will present at the 12th Annual Rodman & Renshaw Global Investment Conference. The conference will be held September 12-15 at The New York Palace Hotel in New York, NY. Mr. Mayleben will present at 3:15 PM ET on Monday, September 13, 2010, in the Fahnestock Salon (5th Floor).
